Skip to main content

Table 7 Comparison of hsa-miR-148a-3p and hsa-miR-125b-5p expression between mature breast milk and commercial infant formulae

From: Expression profiles of hsa-miR-148a-3p and hsa-miR-125b-5p in human breast milk and infant formulae

 

Mature milk

(n = 16)

Japanese Infant Formulae

a

b

c

d

e

f

miR-148a

Mean

1.00

5.70E-04*

1.38E-03*

6.34E-03*

1.41E-03*

6.60E-05*

3.39E-05*

SD

0.76

5.32E-05

1.09E-04

6.00E-05

5.51E-04

3.01E-06

3.52E-05

miR-125b

Mean

1.00

3.06E-03*

8.24E-03*

3.78E-03*

6.87E-03*

3.93E-04*

2.02E-03*

SD

0.64

7.79E-04

6.48E-04

3.57E-04

2.17E-03

1.80E-05

2.10E-04

  1. The expression of hsa-miR-148a-3p (miR-148a) and hsa-miR-125b-5p (miR-125b) was analyzed using quantitative RT-PCR and normalized to that of spike-in control cel-miR-39. Six infant formulae (a–f) were analyzed. The levels of miR-148a and miR-125b in each infant formulae were compared with breast milk samples obtained from 16 Japanese healthy nursing women 30 days after delivery (mature milk). *P < 0.05, compared with mature milk, the Dunnett’s multiple test. Data are presented as mean and standard deviation (SD)